When we evaluated the action of Erk1/2 and PI3K inhibitors on the expression of AR after stimulation with DHT, we observed that the concomitant administration of BEZ235 was not able to reduce AR expression as observed previously when given alone.
Thus, if an incomplete desensitization of 5-HT1A autoreceptors is actually responsible for the silencing of 50% of 5-HT neurons at day 3 (see above), it is reasonable to expect a recovery after 2-3 weeks, as observed when citalopram is given alone [9], [30].
Coadministration of dolutegravir with boceprevir had no significant effects on dolutegravir AUC0 τ, Cmax and Cτ, with changes of <10% for each parameter observed when dolutegravir was given alone compared with coadministration.
Given alone, no mutagenic or recombinogenic effects could be observed.
The non-haematologic toxicities we observed for this combination were similar to those previously reported for BMS-184476 given alone and in combination.
In addition to the above, we also observed that potent-AhR agonists could suppress both CXCL8 and CCL5-responses by TLR-ligands, but given alone at sufficiently high concentrations, they elicited a moderate activation of CXCL8.
Applying this optimal schedule of combined therapy, we observed a significant decrease of tumor growth, and also a prolongation of survival time of mice in comparison with 5-FU given alone.
When given alone PACAP6 38 induced a slight dilation, but no significant inhibition of PACAP1 38 induced dilation of middle meningeal arteries was observed [33].
Applying the optimal schedule of combined therapy we observed a significant decrease in tumor growth, metastasis and also a prolongation of the survival time of mice, in comparison with the administrations of 5-FU given alone.
Such drugs could be given alone.
